Krka Q1 Revenues and Profit Flat
Ljubljana, 14 May - Pharma company Krka generated revenues of EUR 245.2m and a net profit of EUR 43.9m in the first quarter of 2009, which is on par with that from the same period a year ago. The crisis has impacted Krka on markets where local currencies have been devalued, the group's chairman Joze Colaric told the press in Novo mesto on Thursday.
Ljubljana
The chairman of pharma company Krka, Joze Colaric, speaking to the press about Krka's results in the first quarter of 2009.
Phto: Rasto Bozic/STA
Ljubljana
The chairman of pharma company Krka, Joze Colaric, speaking to the press about Krka's results in the first quarter of 2009.
Phto: Rasto Bozic/STA
Ljubljana
The chairman of pharma company Krka, Joze Colaric (centre), speaking to the press about Krka's results in the first quarter of 2009.
Phto: Rasto Bozic/STA
The rest of this news item is available to subscribers.
The news item consists of 1.708 characters (without spaces) or 355 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.